- Patients who moved from weight-loss injections to Novo Nordisk's daily Wegovy pill continued to lose weight, according to data unveiled at a medical meeting on Wednesday.
- The Danish drugmaker is using the real-world evidence to defend its lead over US rival Eli Lilly in the obesity market.
- Wegovy tablets are already being produced at Novo Nordisk's facility in Malov, west of Copenhagen.
引述
“Patients who switched from weight-loss injections to Novo Nordisk's(NOVOb.CO), opens new tab daily Wegovy pill continued to lose weight, according to data unveiled at a medical meeting on Wednesday”
“as the Danish drugmaker seeks to defend its lead over US rival Eli Lilly(LLY.N), opens new tab”